FENC
Fennec Pharmaceuticals Inc
NASDAQ: FENC · HEALTHCARE · BIOTECHNOLOGY
$7.03
-5.02% today
Updated 2026-06-05
Market cap
$302.21M
P/E ratio
—
P/S ratio
5.93x
EPS (TTM)
$-0.29
Dividend yield
—
52W range
$6 – $10
Volume
0.3M
Fennec Pharmaceuticals Inc (FENC) Insider transactions
Net insider activity
Net selling (443,084 shares)
Buy transactions
67
Sell transactions
33
All transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-10 | RALLIS, CHRIS A | Director | Buy | 20,000 | $8.70 | $174000.00 |
| 2026-06-10 | ISLAM, KHALID | Director | Buy | 25,000 | $8.70 | $217500.00 |
| 2026-06-10 | COOK, JODI A | Director | Buy | 20,000 | $8.70 | $174000.00 |
| 2026-06-10 | BRUGHERA, MARCO MARIA | Director | Buy | 20,000 | $8.70 | $174000.00 |
| 2026-06-01 | RAYKOV, ROSTY | Director | Sale | 15,597 | $2.45 | $38212.65 |
| 2026-06-01 | RAYKOV, ROSTY | Director | Buy | 15,597 | $2.45 | $38212.65 |
| 2026-06-01 | RAYKOV, ROSTY | Director | Sale | 9,747 | $9.62 | $93766.14 |
| 2026-05-31 | SAYAD, PIERRE SARGIS | Chief Medical Officer | Buy | 168 | — | — |
| 2026-05-31 | RAYKOV, ROSTY | Director | Buy | 2,778 | — | — |
| 2026-05-31 | HACKMAN, JEFFREY S. | Director, Chief Executive Officer | Buy | 1,159 | — | — |
| 2026-05-31 | EVANS, TERRY L | Chief Commercial Officer | Buy | 168 | — | — |
| 2026-05-31 | CIOFFI, CHRISTIANA MARIE | Chief Strategy Officer | Buy | 156 | — | — |
| 2026-05-31 | ANDRADE, ROBERT | CHIEF FINANCIAL OFFICER | Buy | 1,703 | — | — |
| 2026-05-11 | RALLIS, CHRIS A | Director | Sale | 14,344 | $2.44 | $34999.36 |
| 2026-05-11 | RALLIS, CHRIS A | Director | Buy | 14,344 | $2.44 | $34999.36 |
| 2026-05-11 | RALLIS, CHRIS A | Director | Sale | 8,346 | $7.04 | $58755.84 |
| 2026-05-01 | RAYKOV, ROSTY | Director | Sale | 15,598 | $2.45 | $38215.10 |
| 2026-05-01 | RAYKOV, ROSTY | Director | Buy | 15,598 | $2.45 | $38215.10 |
| 2026-05-01 | RAYKOV, ROSTY | Director | Sale | 10,781 | $6.47 | $69753.07 |
| 2026-04-30 | SAYAD, PIERRE SARGIS | Chief Medical Officer | Buy | 168 | — | — |
| 2026-04-30 | RAYKOV, ROSTY | Director | Buy | 2,778 | — | — |
| 2026-04-30 | HACKMAN, JEFFREY S. | Director, Chief Executive Officer | Buy | 1,159 | — | — |
| 2026-04-30 | EVANS, TERRY L | Chief Commercial Officer | Buy | 168 | — | — |
| 2026-04-30 | CIOFFI, CHRISTIANA MARIE | Chief Strategy Officer | Buy | 155 | — | — |
| 2026-04-30 | ANDRADE, ROBERT | CHIEF FINANCIAL OFFICER | Buy | 1,703 | — | — |
| 2026-04-01 | RAYKOV, ROSTY | Director | Sale | 15,598 | $2.45 | $38215.10 |
| 2026-04-01 | RAYKOV, ROSTY | Director | Buy | 15,598 | $2.45 | $38215.10 |
| 2026-04-01 | RAYKOV, ROSTY | Director | Sale | 10,946 | $6.31 | $69069.26 |
| 2026-03-31 | SAYAD, PIERRE SARGIS | Chief Medical Officer | Buy | 120,000 | $5.77 | $692400.00 |
| 2026-03-31 | SAYAD, PIERRE SARGIS | Chief Medical Officer | Buy | 18,456 | — | — |
| 2026-03-31 | SAYAD, PIERRE SARGIS | Chief Medical Officer | Buy | 171 | — | — |
| 2026-03-31 | RAYKOV, ROSTY | Director | Buy | 5,208 | — | — |
| 2026-03-31 | HACKMAN, JEFFREY S. | Director, Chief Executive Officer | Buy | 200,000 | $5.77 | $1.15M |
| 2026-03-31 | HACKMAN, JEFFREY S. | Director, Chief Executive Officer | Buy | 16,695 | — | — |
| 2026-03-31 | HACKMAN, JEFFREY S. | Director, Chief Executive Officer | Buy | 1,159 | — | — |
| 2026-03-31 | EVANS, TERRY L | Chief Commercial Officer | Buy | 120,000 | $5.77 | $692400.00 |
| 2026-03-31 | EVANS, TERRY L | Chief Commercial Officer | Buy | 18,456 | — | — |
| 2026-03-31 | EVANS, TERRY L | Chief Commercial Officer | Buy | 171 | — | — |
| 2026-03-31 | CIOFFI, CHRISTIANA MARIE | Chief Strategy Officer | Buy | 120,000 | $5.77 | $692400.00 |
| 2026-03-31 | CIOFFI, CHRISTIANA MARIE | Chief Strategy Officer | Buy | 17,106 | — | — |
| 2026-03-31 | CIOFFI, CHRISTIANA MARIE | Chief Strategy Officer | Buy | 158 | — | — |
| 2026-03-31 | ANDRADE, ROBERT | CHIEF FINANCIAL OFFICER | Buy | 120,000 | $5.77 | $692400.00 |
| 2026-03-31 | ANDRADE, ROBERT | CHIEF FINANCIAL OFFICER | Buy | 14,724 | — | — |
| 2026-03-31 | ANDRADE, ROBERT | CHIEF FINANCIAL OFFICER | Buy | 2,213 | — | — |
| 2026-03-28 | SAYAD, PIERRE SARGIS | Chief Medical Officer | Buy | 2,052 | — | — |
| 2026-03-28 | HACKMAN, JEFFREY S. | Director, Chief Executive Officer | Buy | 13,943 | — | — |
| 2026-03-28 | EVANS, TERRY L | Chief Commercial Officer | Buy | 2,052 | — | — |
| 2026-03-28 | CIOFFI, CHRISTIANA MARIE | Chief Strategy Officer | Buy | 1,901 | — | — |
| 2026-03-28 | ANDRADE, ROBERT | CHIEF FINANCIAL OFFICER | Buy | 12,270 | — | — |
| 2026-03-26 | CIOFFI, CHRISTIANA MARIE | Chief Strategy Officer | Sale | 4,700 | $4.23 | $19881.00 |
| 2026-03-26 | CIOFFI, CHRISTIANA MARIE | Chief Strategy Officer | Buy | 4,700 | $4.23 | $19881.00 |
| 2026-03-26 | ANDRADE, ROBERT | CHIEF FINANCIAL OFFICER | Sale | 13,072 | $5.10 | $66667.20 |
| 2026-03-26 | ANDRADE, ROBERT | CHIEF FINANCIAL OFFICER | Buy | 13,072 | $5.10 | $66667.20 |
| 2026-03-02 | RAYKOV, ROSTY | Director | Sale | 15,598 | $2.45 | $38215.10 |
| 2026-03-02 | RAYKOV, ROSTY | Director | Buy | 15,598 | $2.45 | $38215.10 |
| 2026-03-02 | RAYKOV, ROSTY | Director | Sale | 10,079 | $8.36 | $84260.44 |
| 2026-02-28 | RAYKOV, ROSTY | Director | Buy | 5,208 | — | — |
| 2026-02-28 | ANDRADE, ROBERT | CHIEF FINANCIAL OFFICER | Buy | 1,191 | — | — |
| 2026-02-18 | HACKMAN, JEFFREY S. | Director, Chief Executive Officer | Buy | 13,710 | — | — |
| 2026-02-18 | ANDRADE, ROBERT | CHIEF FINANCIAL OFFICER | Sale | 2,450 | $4.08 | $9996.00 |
| 2026-02-18 | ANDRADE, ROBERT | CHIEF FINANCIAL OFFICER | Buy | 27,285 | — | — |
| 2026-02-18 | ANDRADE, ROBERT | CHIEF FINANCIAL OFFICER | Buy | 2,450 | $4.08 | $9996.00 |
| 2026-02-02 | RAYKOV, ROSTY | Director | Sale | 15,598 | $2.45 | $38215.10 |
| 2026-02-02 | RAYKOV, ROSTY | Director | Buy | 15,598 | $2.45 | $38215.10 |
| 2026-02-02 | RAYKOV, ROSTY | Director | Sale | 10,349 | $7.76 | $80308.24 |
| 2026-01-31 | RAYKOV, ROSTY | Director | Buy | 5,208 | — | — |
| 2026-01-31 | ANDRADE, ROBERT | CHIEF FINANCIAL OFFICER | Buy | 1,558 | — | — |
| 2026-01-23 | ANDRADE, ROBERT | CHIEF FINANCIAL OFFICER | Sale | 10,000 | $2.45 | $24500.00 |
| 2026-01-23 | ANDRADE, ROBERT | CHIEF FINANCIAL OFFICER | Buy | 10,000 | $2.45 | $24500.00 |
| 2026-01-15 | ANDRADE, ROBERT | CHIEF FINANCIAL OFFICER | Sale | 10,000 | $2.45 | $24500.00 |
| 2026-01-15 | ANDRADE, ROBERT | CHIEF FINANCIAL OFFICER | Buy | 10,000 | $2.45 | $24500.00 |
| 2026-01-07 | ANDRADE, ROBERT | CHIEF FINANCIAL OFFICER | Sale | 14,184 | $2.45 | $34750.80 |
| 2026-01-07 | ANDRADE, ROBERT | CHIEF FINANCIAL OFFICER | Buy | 14,184 | $2.45 | $34750.80 |
| 2026-01-02 | RAYKOV, ROSTY | Director | Sale | 15,598 | $2.45 | $38215.10 |
| 2026-01-02 | RAYKOV, ROSTY | Director | Buy | 15,598 | $2.45 | $38215.10 |
| 2026-01-02 | RAYKOV, ROSTY | Director | Sale | 10,312 | $7.60 | $78371.20 |
| 2025-12-31 | RAYKOV, ROSTY | Director | Buy | 5,208 | — | — |
| 2025-12-31 | ANDRADE, ROBERT | CHIEF FINANCIAL OFFICER | Buy | 1,382 | — | — |
| 2025-12-24 | SOUTHPOINT, CAPITAL ADVISORS LP | 10% Owner | Sale | 1,000,000 | $7.50 | $7.50M |
| 2025-12-05 | RAYKOV, ROSTY | Director | Sale | 10,000 | $7.54 | $75400.00 |
| 2025-12-01 | RAYKOV, ROSTY | Director | Buy | 5,208 | — | — |
| 2025-12-01 | ANDRADE, ROBERT | CHIEF FINANCIAL OFFICER | Buy | 2,430 | — | — |
| 2025-11-18 | SOUTHPOINT, CAPITAL ADVISORS LP | 10% Owner | Sale | 19,341 | $8.79 | $170048.01 |
| 2025-11-17 | SOUTHPOINT, CAPITAL ADVISORS LP | 10% Owner | Sale | 85,918 | $8.79 | $755193.44 |
| 2025-11-14 | SOUTHPOINT, CAPITAL ADVISORS LP | 10% Owner | Sale | 160,100 | $8.00 | $1.28M |
| 2025-11-05 | RAYKOV, ROSTY | Director | Sale | 10,000 | $8.10 | $81000.00 |
| 2025-10-31 | RAYKOV, ROSTY | Director | Buy | 5,208 | — | — |
| 2025-10-31 | ANDRADE, ROBERT | CHIEF FINANCIAL OFFICER | Buy | 2,430 | — | — |
| 2025-10-10 | RALLIS, CHRIS A | Director | Buy | 4,062 | $1.23 | $4996.26 |
| 2025-10-10 | RALLIS, CHRIS A | Director | Sale | 1,775 | $9.24 | $16401.00 |
| 2025-10-09 | SOUTHPOINT, CAPITAL ADVISORS LP | 10% Owner | Sale | 20,609 | $9.35 | $192613.77 |
| 2025-10-08 | SOUTHPOINT, CAPITAL ADVISORS LP | 10% Owner | Sale | 19,605 | $9.47 | $185722.09 |
| 2025-10-08 | RAYKOV, ROSTY | Director | Sale | 4,609 | $2.45 | $11292.05 |
| 2025-10-08 | RAYKOV, ROSTY | Director | Buy | 4,609 | $2.45 | $11292.05 |
| 2025-10-07 | SOUTHPOINT, CAPITAL ADVISORS LP | 10% Owner | Sale | 26,900 | $9.59 | $257892.99 |
| 2025-10-06 | RAYKOV, ROSTY | Director | Sale | 10,000 | $9.78 | $97800.00 |
| 2025-09-30 | RAYKOV, ROSTY | Director | Buy | 5,208 | — | — |
| 2025-09-30 | ANDRADE, ROBERT | CHIEF FINANCIAL OFFICER | Buy | 2,430 | — | — |
| 2025-09-05 | RAYKOV, ROSTY | Director | Sale | 36,207 | $2.45 | $88707.15 |
| 2025-09-05 | RAYKOV, ROSTY | Director | Buy | 36,207 | $2.45 | $88707.15 |
Frequently asked questions
Are FENC insiders buying or selling?
Over the transactions on record, FENC insiders have been net buyers, with about $11.69M in stock sold across 33 sales, against 25 open-market purchases.
Does insider selling at FENC mean the stock will fall?
Not by itself. Most executive selling is pre-scheduled through 10b5-1 plans filed months in advance, and insiders sell for diversification, taxes, and liquidity far more often than out of any view on the price. Insider buying is the stronger signal, especially when several insiders buy around the same time, because there is usually only one reason to put personal cash into the stock.
Which FENC insiders are selling the most?
Recent selling is concentrated in a few names. SOUTHPOINT, CAPITAL ADVISORS LP accounts for the largest share on record, with about $10.34M sold. Selling by one or two individuals matters less than broad selling across the whole leadership team, which is the pattern worth watching.